Aspireo Pharmaceuticals Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $33.2M

Aspireo Pharmaceuticals General Information

Description

Developer of somatostatin analogs for the treatment of diseases resulting from hormone-active tumors. The company offers Somatoprim, a novel somatostatin analog used to treat patients with disorders such as diabetic retinopathy and cushings diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • PO Box 880
  • Ra'anana 43108
  • Israel
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • PO Box 880
  • Ra'anana 43108
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspireo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 30-Jun-2015 $33.2M Completed Generating Revenue
1. Early Stage VC 01-Dec-2010 Completed Startup
To view Aspireo Pharmaceuticals’s complete valuation and funding history, request access »

Aspireo Pharmaceuticals Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
TVM Capital Life Science Venture Capital Minority
To view Aspireo Pharmaceuticals’s complete investors history, request access »

Aspireo Pharmaceuticals FAQs

  • When was Aspireo Pharmaceuticals founded?

    Aspireo Pharmaceuticals was founded in 2010.

  • Where is Aspireo Pharmaceuticals headquartered?

    Aspireo Pharmaceuticals is headquartered in Ra'anana, Israel.

  • What industry is Aspireo Pharmaceuticals in?

    Aspireo Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Aspireo Pharmaceuticals a private or public company?

    Aspireo Pharmaceuticals is a Private company.

  • What is the current valuation of Aspireo Pharmaceuticals?

    The current valuation of Aspireo Pharmaceuticals is .

  • What is Aspireo Pharmaceuticals’s current revenue?

    The current revenue for Aspireo Pharmaceuticals is .

  • Who are Aspireo Pharmaceuticals’s investors?

    TVM Capital Life Science has invested in Aspireo Pharmaceuticals.

  • When was Aspireo Pharmaceuticals acquired?

    Aspireo Pharmaceuticals was acquired on 30-Jun-2015.

  • Who acquired Aspireo Pharmaceuticals?

    Aspireo Pharmaceuticals was acquired by Strongbridge Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »